89bio is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of liver and metabolic diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: 142 Sansome Street
City: San Francisco
State: CA
Zip: 94104
Country: US
89bio is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of liver and metabolic diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/11/2019
Ticker Symbol:
ETNB
IPO Price:
$16/share
Amount Raised:
$85M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2022 | Post-IPO Equity | $94.5M | 10/2018 | Series A | 4 | $60M |
RA Capital Management Longitude Capital OrbiMed Pontifax Longitude Capital OrbiMed RA Capital Management Longitude Capital OrbiMed Pontifax Longitude Capital OrbiMed |
11/2019 | IPO | $84.9M |
|
7/2022 | Post-IPO Equity | $94.5M |
BVF Partners L.P Deep Track Capital RA Capital Management Braidwell LP Janus Henderson Investors |
7/2020 | Post-IPO Secondary | $83.8M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|